G1 Therapeutics Inc (GTHX) Actualités

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

- Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive...

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period

HOLBAEK, Denmark and RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a...

Form SC 14D9 - Solicitation, recommendation statements

Form SC TO-T - Tender offer statement by Third Party